Canadian National PDA Treatment Study
Launched by IWK HEALTH CENTRE · Apr 12, 2020
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
In this study, we intend to generate real-world evidence (RWE) by analyzing real-world data (RWD) (defined as data generated during routine clinical practice) from a registry-based Comparative Effectiveness Research study.
The Canadian Neonatal Network (CNN) is a well-established patient registry that includes members from 31 hospitals and 17 universities across Canada. The Network maintains a standardized NICU database and provides a unique opportunity for researchers to participate in collaborative projects. We will use the principles of Hypotheses Evaluating Treatment Effectiveness (HET...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Extremely preterm infants (\<29 weeks gestational age) with an echocardiography confirmed PDA who will be treated according to attending team
- Exclusion Criteria:
- • Any infant who received pharmacotherapy for a clinically symptomatic PDA without prior echocardiographic confirmation of the presence of PDA will be excluded from all analyses.
About Iwk Health Centre
IWK Health Centre is a leading pediatric and women's health facility based in Halifax, Nova Scotia, dedicated to providing high-quality care and advancing medical research. As a prominent clinical trial sponsor, IWK Health Centre collaborates with multidisciplinary teams to conduct innovative research aimed at improving health outcomes for children, youth, and women. The center prioritizes patient-centered approaches in its trials, ensuring that the needs and safety of participants are at the forefront of its research initiatives. With a commitment to excellence and ethical standards, IWK Health Centre contributes significantly to the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Ottawa, Ontario, Canada
Saskatoon, Saskatchewan, Canada
Winnipeg, Manitoba, Canada
Winnipeg, Manitoba, Canada
Saint John, New Brunswick, Canada
London, Ontario, Canada
Calgary, Alberta, Canada
Victoria, British Columbia, Canada
Winnipeg, Manitoba, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Edmonton, Alberta, Canada
Windsor, Ontario, Canada
Toronto, Ontario, Canada
Sherbrooke, Quebec, Canada
New Westminster, British Columbia, Canada
Moncton, New Brunswick, Canada
Halifax, Nova Scotia, Canada
London, , Canada
Regina, Saskatchewan, Canada
Kingston, Ontario, Canada
Montréal, Quebec, Canada
Kingston, , Canada
Vancouver, British Columbia, Canada
Québec City, Quebec, Canada
Patients applied
Trial Officials
Souvik Mitra, MD, MSc
Principal Investigator
IWK Health Center, Halifax, Canada
Amish Jain, MBBS, PhD
Principal Investigator
Mount Sinai Hospital, Canada
Prakeshkumar Shah, MD, FRCPC
Principal Investigator
Mount Sinai Hospital, Canada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials